Related Experiment Video
Updated: Feb 7, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
Early Treatment Response Predicts Outcome in Paediatric Ulcerative Colitis: GASTROENTEROLOGY: INFLAMMATORY BOWEL
Marco Gasparetto1,2, Vivien Wong-Spracklen2, Franco Torrente2
1Department of Paediatrics, University of Cambridge, Addenbrooke's Hospital.
Insights
Predicting severe pediatric ulcerative colitis (UC) is crucial. Early identification of severe disease course in children with UC using clinical factors can guide timely interventions, potentially avoiding biologics or surgery.
Area of Science:
- Pediatric Gastroenterology
- Inflammatory Bowel Disease Research
- Clinical Outcome Prediction
Background:
- The disease course of pediatric ulcerative colitis (UC) is highly variable.
- Limited data exists on predictors for disease outcomes in pediatric UC patients.
Purpose of the Study:
- To validate clinical predictors of disease outcomes in a cohort of pediatric UC patients.
- To identify factors associated with a severe disease course in children with UC.
Main Methods:
- Retrospective analysis of 93 pediatric UC patients (age 2-18 years) with a minimum 18-month follow-up.
- Stratification into mild, moderate, and severe disease course groups.
- Statistical comparison of clinical and biochemical parameters using Chi-square, Mann-Whitney, and log-rank tests.
Main Results:
- Predictors of a severe disease course included pancolitis, low albumin, low hemoglobin at diagnosis, high pediatric ulcerative colitis activity index (PUCAI) at 3 months, and nonresponse to steroids at 3 months.
- Failure to achieve remission at 3 months was associated with an 80% likelihood of requiring biologics or major surgery within 18 months.
Conclusions:
- Clinical factors at diagnosis and early disease markers (3-month assessment) are significant predictors of long-term outcomes in pediatric UC.
- A 3-month review point is recommended to guide management decisions for children with UC, potentially altering the disease trajectory.
Abstract:
The disease course of children with ulcerative colitis (UC) varies substantially. Published data on predictors of disease outcomes in children remain scarce. We validate clinical predictors of outcomes in 93 children with UC in a single centre (age range: 2-18 years, minimum follow-up: 18 months). We stratified children into 3 groups according to their disease course, that is, 1 = mild (38/93, 40.9%), 2 = moderate (38/93, 40.9%), 3 = severe (17, 18.2%). Comparison of clinical and biochemical parameters was performed between groups using Chi-square, Mann-Whitney, and log-rank tests. Predictors of a severe disease course included pancolitis (P 0.01), low albumin (P 0.005), low haemoglobin at diagnosis (P 0.04), paediatric ulcerative colitis activity index (PUCAI) at 3 months, and nonresponse to steroids at 3 months (P 0.0001). In our cohort, failure to achieve remission at 3 months implied an 80% likelihood to require biologics or major surgery within 18 months. A specific 3-month review point is recommended to guide future management.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Predicting Reaction Outcomes

